For instance, low BChE level was revealed as an independent marker of shorter survival time in colorectal carcinoma, upper tract urothelial carcinoma, clear cell renal cell carcinoma, prostate cancer and cervical cancer [19,20,21,22,23,24]. This evidence concerns the gene BCHE and colorectal carcinoma.